These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 1834088)
1. Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonist. Schoepp DD; Ornstein PL; Salhoff CR; Leander JD J Neural Transm Gen Sect; 1991; 85(2):131-43. PubMed ID: 1834088 [TBL] [Abstract][Full Text] [Related]
2. 4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action. Ornstein PL; Schoepp DD; Arnold MB; Leander JD; Lodge D; Paschal JW; Elzey T J Med Chem; 1991 Jan; 34(1):90-7. PubMed ID: 1825117 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. Foster AC; Gill R; Woodruff GN J Neurosci; 1988 Dec; 8(12):4745-54. PubMed ID: 2904493 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action. Schoepp DD; Ornstein PL; Leander JD; Lodge D; Salhoff CR; Zeman S; Zimmerman DM J Pharmacol Exp Ther; 1990 Dec; 255(3):1301-8. PubMed ID: 2148188 [TBL] [Abstract][Full Text] [Related]
5. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain. Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317 [TBL] [Abstract][Full Text] [Related]
6. Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage. Benavides J; Fage D; Carter C; Scatton B Brain Res; 1987 Sep; 421(1-2):167-72. PubMed ID: 2891401 [TBL] [Abstract][Full Text] [Related]
7. Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist. Fuller RW; Hemrick-Luecke SK; Ornstein PL Neuropharmacology; 1992 Oct; 31(10):1027-32. PubMed ID: 1436384 [TBL] [Abstract][Full Text] [Related]
9. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. Pittaluga A; Raiteri M J Pharmacol Exp Ther; 1992 Jan; 260(1):232-7. PubMed ID: 1370540 [TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy. Massieu L; Thedinga KH; McVey M; Fagg GE Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181 [TBL] [Abstract][Full Text] [Related]
11. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials. Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583 [TBL] [Abstract][Full Text] [Related]
12. Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease. Dure LS; Young AB; Penney JB Ann Neurol; 1991 Dec; 30(6):785-93. PubMed ID: 1665055 [TBL] [Abstract][Full Text] [Related]
13. CGS-19755 and MK-801 selectively prevent rat striatal cholinergic and gabaergic neuronal degeneration induced by N-methyl-D-aspartate and ibotenate in vivo. Schoepp DD; Salhoff CR; Hillman CC; Ornstein PL J Neural Transm Gen Sect; 1989; 78(3):183-93. PubMed ID: 2553073 [TBL] [Abstract][Full Text] [Related]
14. Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones. D'Hooge R; Raes A; Van de Vijver G; Van Bogaert PP; De Deyn PP Fundam Clin Pharmacol; 1999; 13(1):67-74. PubMed ID: 10027090 [TBL] [Abstract][Full Text] [Related]
15. Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection. Krogsgaard-Larsen P; Ferkany JW; Nielsen EO; Madsen U; Ebert B; Johansen JS; Diemer NH; Bruhn T; Beattie DT; Curtis DR J Med Chem; 1991 Jan; 34(1):123-30. PubMed ID: 1825114 [TBL] [Abstract][Full Text] [Related]